19th Jan 2022 09:26
4basebio PLC - Cambridge, England-based biotechnology - Announces a research collaboration between its subsidiary 4basebio Discovery Ltd and the Niel, Belgium-based peer eTheRNA immunotherapies NV. Says the companies will work on the use of 4basebio's synthetic osDNA technology as a template for eTheRNA's in vitro mRNA production. A successful outcome of this research collaboration could pave the way for the use of a new and cost-effective DNA template for in vitro transcription mRNA synthesis, 4basebio says.
Current stock price: 600.00 pence
12-month change: up 78%
By Abby Amoakuh; [email protected]
Copyright 2022 Alliance News Limited. All Rights Reserved.
Related Shares:
4basebio Plc